CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine | Inquirer News

CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine

/ 06:57 AM November 17, 2021

FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014.  REUTERS/Tami Chappell

FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to discuss expanding the eligibility for booster doses of Pfizer and partner BioNTech’s COVID-19 vaccine, currently allowed for select groups of people.

Earlier this month, Pfizer had requested the U.S. Food and Drug Administration (FDA) to authorize booster doses of the vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages.

Article continues after this advertisement

The company’s third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.

FEATURED STORIES

U.S. President Joe Biden’s administration in August announced plans to roll out booster doses for all adults in September.

The CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.